{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T20:58:25Z","timestamp":1761857905777,"version":"build-2065373602"},"reference-count":12,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","pathologyjournal.rcpa.edu.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.pathol.2021.11.009","type":"journal-article","created":{"date-parts":[[2022,2,10]],"date-time":"2022-02-10T17:24:23Z","timestamp":1644513863000},"page":"820-823","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["A case of steroid responsive nivolumab induced cholangitis"],"prefix":"10.1016","volume":"54","author":[{"given":"Andrew","family":"Kynaston","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0453-3168","authenticated-orcid":false,"given":"Ken","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5390-8133","authenticated-orcid":false,"given":"Alex","family":"Davis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven","family":"Kao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catriona","family":"McKenzie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.pathol.2021.11.009_bib1","first-page":"173","article-title":"Immune checkpoint inhibitors (ICIs) in non-small cell lung cancer (NSCLC)","volume":"40","author":"Yoneda","year":"2018","journal-title":"J\u00a0UOEH"},{"key":"10.1016\/j.pathol.2021.11.009_bib2","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/nrc3239","article-title":"The blockade of immune checkpoints in cancer immunotherapy","volume":"12","author":"Pardoll","year":"2012","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.pathol.2021.11.009_bib3","doi-asserted-by":"crossref","first-page":"5376","DOI":"10.3748\/wjg.v27.i32.5376","article-title":"Immune checkpoint inhibitor-related hepatotoxicity: a review","volume":"27","author":"Remash","year":"2021","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.pathol.2021.11.009_bib4","doi-asserted-by":"crossref","first-page":"353","DOI":"10.3748\/wjg.v26.i3.353","article-title":"Programmed cell death-1 inhibitor-related sclerosing cholangitis: a systematic review","volume":"26","author":"Onoyama","year":"2020","journal-title":"World J Gastroenterol"},{"journal-title":"Canberra: Australian Government Department of Health,","article-title":"Australian Public Assessment Report for Nivolumab: January, 2020","year":"2020","key":"10.1016\/j.pathol.2021.11.009_bib5"},{"key":"10.1016\/j.pathol.2021.11.009_bib6","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1093\/annonc\/mdw649","article-title":"Nivolumab-induced cholangitic liver disease: a novel form of serious liver injury","volume":"28","author":"Gelsomino","year":"2017","journal-title":"Ann Oncol"},{"key":"10.1016\/j.pathol.2021.11.009_bib7","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgast-2020-000487","article-title":"Case of nivolumab-induced sclerosing cholangitis: lessons from long-term follow-up","volume":"7","author":"McClure","year":"2020","journal-title":"BMJ Open Gastroenterol"},{"key":"10.1016\/j.pathol.2021.11.009_bib8","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s12328-020-01287-1","article-title":"A\u00a0case with life-threatening secondary sclerosing cholangitis caused by nivolumab","volume":"14","author":"Yoshikawa","year":"2021","journal-title":"J\u00a0Clin Gastroenterol"},{"key":"10.1016\/j.pathol.2021.11.009_bib9","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2021-241700","article-title":"Sclerosing cholangitis in a patient treated with nivolumab","volume":"14","author":"Talbot","year":"2021","journal-title":"BMJ Case Rep"},{"key":"10.1016\/j.pathol.2021.11.009_bib10","article-title":"A\u00a0case report on severe nivolumab-induced adverse events similar to primary sclerosing cholangitis refractory to immunosuppressive therapy","volume":"100","author":"Hirasawa","year":"2021","journal-title":"J\u00a0Med"},{"key":"10.1016\/j.pathol.2021.11.009_bib11","doi-asserted-by":"crossref","first-page":"6391712","DOI":"10.1155\/2019\/6391712","article-title":"Clinical features of liver injury induced by immune checkpoint inhibitors in Japanese patients","volume":"2019","author":"Imoto","year":"2019","journal-title":"Can J Gastroenterol Hepatol"},{"key":"10.1016\/j.pathol.2021.11.009_bib12","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1007\/s10637-017-0453-0","article-title":"Imaging and clinicopathological features of nivolumab-related cholangitis in patients with non-small cell lung cancer","volume":"35","author":"Kawakami","year":"2017","journal-title":"Invest New Drugs"}],"container-title":["Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031302522000319?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031302522000319?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T16:29:13Z","timestamp":1758472153000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0031302522000319"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":12,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["S0031302522000319"],"URL":"https:\/\/doi.org\/10.1016\/j.pathol.2021.11.009","relation":{},"ISSN":["0031-3025"],"issn-type":[{"type":"print","value":"0031-3025"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A case of steroid responsive nivolumab induced cholangitis","name":"articletitle","label":"Article Title"},{"value":"Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pathol.2021.11.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2022 Published by Elsevier B.V. on behalf of Royal College of Pathologists of Australasia. All rights reserved.","name":"copyright","label":"Copyright"}]}}